Milestones in treatment: The tipping point and the ResQ Trial

Demetris Yannopoulos, Tom P. Aufderheide, Ralph J. Frascone, Marvin A. Wayne, Brian D. Mahoney, Robert A. Swor, Robert M. Domeier, Michael L. Olinger, Richard G. Holcomb, David E. Tupper

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2081-2082
Number of pages2
JournalThe Lancet
Volume377
Issue number9783
DOIs
StatePublished - Jun 18 2011

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yannopoulos, D., Aufderheide, T. P., Frascone, R. J., Wayne, M. A., Mahoney, B. D., Swor, R. A., Domeier, R. M., Olinger, M. L., Holcomb, R. G., & Tupper, D. E. (2011). Milestones in treatment: The tipping point and the ResQ Trial. The Lancet, 377(9783), 2081-2082. https://doi.org/10.1016/S0140-6736(11)60914-8